Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study (Q33408942)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Michela Casanova

object named as

Michela Casanova

15

0 references

Piotr Czauderna

18

object named as

Piotr Czauderna

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

object named as

Penelope Brock

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

József Zsiros

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Laurence Brugieres

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Derek Roebuck

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rudolf Maibach

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Arthur Zimmermann

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Margaret Childs

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Daniele Pariente

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Veronique Laithier

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jean-Bernard Otte

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sophie Branchereau

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Daniel Aronson

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Arun Rangaswami

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Milind Ronghe

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Michael Sullivan

16

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Bruce Morland

17

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Giorgio Perilongo

19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

International Childhood Liver Tumours Strategy Group (SIOPEL)

20

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

4 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

834-842

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Dose-Dense Chemotherapy: Principles, Clinical Results and Future Perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Progress in the surgical treatment of malignant liver tumors in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Radiological staging in children with hepatoblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Liver transplantation for hepatoblastoma: indications and contraindications in the modern era

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Guidelines for surgical treatment of hepatoblastoma in the modern era--recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Cisplatin ototoxicity in children: a practical grading system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Weekly administration of cis-dichlorodiammineplatinum(II) in childhood solid tumors: a Southwest Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

21 June 2018

Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

31 October 2018

Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

31 October 2018

Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

31 October 2018

Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

31 October 2018

Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

31 October 2018

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3730732

31 October 2018

Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970272-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970272-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970272-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970272-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970272-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970272-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970272-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Small cell undifferentiated histology in hepatoblastoma may be unfavorable

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970272-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23831416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S1470-2045(13)70272-9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33408942&oldid=2253348552"